Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism
We wish to comment on the Dinger We collected data on the COC prescription rate in Croatia and assessed whether there might be a link with the incidence of VTE. During that period the HALMED recorded 138 side effects and group.bmj.com on October 11, 2017 -Published by http://jfprhc.bmj.com/ Downloaded from complications related to the use of the COCs in the whole of Croatia.
Among these reports of side effects and complications there were 11 cases of verifi ed VTE (including deep vein thromboses, cerebral venous thrombosis, thrombophlebitis superfi cialis and basilar artery thrombosis), nine cases of pulmonary embolism and one case of thrombosis and pulmonary embolism together, whereas the other reports referred to symptoms such as headache (10), nausea (7), muscle spasm (4), and so on.
For women who used DRSP-containing COCs, 17 side effects of thrombosis and pulmonary embolism were registered (0.438 per 1000 women), whereas for women who used other COCs only four side effects were noted (0.068 per 1000 women), which is 6.4-fold less. Thrombosis and embolism as side effects, substances and outcomes when taking various COCs are shown in Table 2 .
However, in over half the cases (n=12) the outcome of thromboembolic complications remained unknown. Recovery was reported in fi ve cases but, as already mentioned, there were two lethal outcomes where a direct causal relationship with the use of COCs could not be determined. We just determined a great difference in rate between these two groups. We can not establish a direct correlation between COC and side effect, but the difference in rates between DRSP-containing COCs and other COCs is fairly great.
Our results should be interpreted very cautiously, especially the 6.4-fold difference found, as our study has great limitations, such as not controlling for confounding variables such as age, weight, smoking, diabetes, prolonged immobilisation, pregnancy, having undergone a surgical procedure, having been subjected to major trauma, cancer, heart failure, family history of VTE, history of contraception, likelihood of biased VTE diagnosis conditional on DRSP use, time from start to event, and so on.
Confounding can never be excluded with certainty in observational studies; it seems that the biases that have been suggested and examined are not suffi cient to account for the results. 2 A survey of medical records of hospitalised women and deaths could determine neither the exact causes nor the outcomes in most cases of VTE. We carefully studied the problems regarding analysis and re-analysis in the Dinger and Shapiro commentary, 1 and because we experienced very similar problems we agree with their claim that the increased risk of VTE among COC users is a class effect. 
